Steven Cohen’s Disc Medicine IRON Stock Holding History

Steven Cohen’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,226	Closed	-$610K	–	4031
2025 Q3	$610K	Buy	+9,226	New	+$549K	﹤0.01%	1859
2025 Q1	–	Sell	-13,444	Closed	-$852K	–	2280
2024 Q4	$852K	Sell	13,444 -742,423	-98%	-$42.9M	﹤0.01%	1515
2024 Q3	$37.1M	Sell	755,867 -5,562	-0.7%	-$261K	0.09%	253
2024 Q2	$34.3M	Buy	+761,429	New	+$25.9M	0.09%	290
2023 Q4	–	Sell	-86,000	Closed	-$4.04M	–	2457
2023 Q3	$4.04M	Sell	86,000 -39,200	-31%	-$1.96M	0.01%	948
2023 Q2	$5.56M	Buy	+125,200	New	+$4.44M	0.02%	784
2021 Q4	–	Sell	-3,119	Closed	-$378K	–	1197
2021 Q3	$378K	Sell	3,119 -3,548	-53%	-$485K	﹤0.01%	942
2021 Q2	$1.29M	Sell	6,667 -9,350	-58%	-$3.07M	0.01%	778
2021 Q1	$6.51M	Buy	+16,017	New	+$7.14M	0.03%	525

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steven Cohen's IRON Position: Q4 2025 in Review

Steven Cohen sold out of Disc Medicine (IRON) in Q4 2025, closing a stake of 9,226 shares — an estimated $610K sold.

Steven Cohen first reported a position in IRON in Q1 2021 and held it in 9 quarters. The position peaked at $37.1M in Q3 2024. 196 funds tracked by Wall St. Rank hold IRON as of Q4 2025.

Steven Cohen reported no remaining Disc Medicine position as of Q4 2025 after selling out during the quarter.
Steven Cohen sold 9,226 Disc Medicine shares in Q4 2025, an estimated $610K.
Steven Cohen first reported a position in Disc Medicine in Q1 2021 and held it in 9 quarters.
Steven Cohen's Disc Medicine position peaked at $37.1M in Q3 2024.
196 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2025.

Based on Point72 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.